Connie M Rhee1, Meijiao Zhou2, Rachael Woznick3, Claudy Mullon2, Michael S Anger2, Linda H Ficociello4. 1. Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine, Orange, CA, USA. 2. Global Medical Office, Fresenius Medical Care, 920 Winter Street, Waltham, MA, 02451, USA. 3. Fresenius Kidney Care, Centre Point, West Allis, WI, USA. 4. Global Medical Office, Fresenius Medical Care, 920 Winter Street, Waltham, MA, 02451, USA. Linda.H.Ficociello@fmc-na.com.
Abstract
OBJECTIVE: Despite the growing number of elderly hemodialysis patients, the influence of age on nutritional parameters, serum phosphorus (sP), and use of phosphate-binder (PB) medications has not been well characterized. We aimed to describe age-related differences in patient characteristics in a large, real-world cohort of maintenance hemodialysis patients, and to examine the impact of age on sP management with sucroferric oxyhydroxide (SO). METHODS: We retrospectively analyzed de-identified data from 2017 adult, in-center hemodialysis patients who switched from another PB to SO monotherapy as part of routine clinical care. Changes in baseline PB pill burden, sP levels, and nutritional and dialytic clearance parameters were assessed across varying age groups through 6 months. RESULTS: At baseline, older patients had lower mean sP, serum albumin, and pre-dialysis weights compared with younger patients. Prescription of SO was associated with a 62% increase in the proportion of patients achieving sP ≤ 5.5 mg/dl and a 42% reduction in daily pill burden. The proportion of patients achieving sP ≤ 5.5 mg/dl after transitioning to SO increased by 113, 96, 68, 77, 61, 37 and 40% among those aged 19-29, 30-39, 40-49, 50-59, 60-69, 70-79, and ≥ 80 years, respectively. CONCLUSIONS: Older patients had worse nutritional parameters, lower pill burden, and lower sP at baseline versus younger counterparts. Prescription of SO was associated with improved sP control and reduced pill burden across all ages.
OBJECTIVE: Despite the growing number of elderly hemodialysis patients, the influence of age on nutritional parameters, serum phosphorus (sP), and use of phosphate-binder (PB) medications has not been well characterized. We aimed to describe age-related differences in patient characteristics in a large, real-world cohort of maintenance hemodialysis patients, and to examine the impact of age on sP management with sucroferric oxyhydroxide (SO). METHODS: We retrospectively analyzed de-identified data from 2017 adult, in-center hemodialysis patients who switched from another PB to SO monotherapy as part of routine clinical care. Changes in baseline PB pill burden, sP levels, and nutritional and dialytic clearance parameters were assessed across varying age groups through 6 months. RESULTS: At baseline, older patients had lower mean sP, serum albumin, and pre-dialysis weights compared with younger patients. Prescription of SO was associated with a 62% increase in the proportion of patients achieving sP ≤ 5.5 mg/dl and a 42% reduction in daily pill burden. The proportion of patients achieving sP ≤ 5.5 mg/dl after transitioning to SO increased by 113, 96, 68, 77, 61, 37 and 40% among those aged 19-29, 30-39, 40-49, 50-59, 60-69, 70-79, and ≥ 80 years, respectively. CONCLUSIONS: Older patients had worse nutritional parameters, lower pill burden, and lower sP at baseline versus younger counterparts. Prescription of SO was associated with improved sP control and reduced pill burden across all ages.
Authors: M Aparicio; N Cano; P Chauveau; R Azar; B Canaud; A Flory; M Laville; X Leverve Journal: Nephrol Dial Transplant Date: 1999-07 Impact factor: 5.992
Authors: Bernard Canaud; Lin Tong; Francesca Tentori; Takashi Akiba; Angelo Karaboyas; Brenda Gillespie; Tadao Akizawa; Ronald L Pisoni; Juergen Bommer; Friedrich K Port Journal: Clin J Am Soc Nephrol Date: 2011-07 Impact factor: 8.237
Authors: Manjula Kurella Tamura; Kenneth E Covinsky; Glenn M Chertow; Kristine Yaffe; C Seth Landefeld; Charles E McCulloch Journal: N Engl J Med Date: 2009-10-15 Impact factor: 91.245
Authors: Xiaoling Ye; Jeroen P Kooman; Frank M van der Sande; Jochen G Raimann; Len A Usvyat; Yuedong Wang; Franklin W Maddux; Peter Kotanko Journal: Clin Kidney J Date: 2019-12-05
Authors: Sara S Kalantar; Amy S You; Keith C Norris; Tracy Nakata; Alejandra Novoa; Kimberly Juarez; Danh V Nguyen; Connie M Rhee Journal: Kidney Med Date: 2019-09-05
Authors: André Weigert; Maciej Drozdz; Fatima Silva; João Frazão; Abdulkareem Alsuwaida; Mahesh Krishnan; Werner Kleophas; Szymon Brzosko; Fredrik K Johansson; Stefan H Jacobson Journal: Clin Kidney J Date: 2019-06-17